Lasers and Ultrasound
 

Featured Videos

Integre Pro Clinical Footage 2: Pan Retinal Photocoagulation (PRP)
Treatment is applied to the retinal periphery. A fast exposure time aided by a precise micromanipulator allows for quick, easy and precise placement over the entire periphery.

Video courtesy of Noor Eye Hospital, Iran

Watch this video

SLT Clinical Footage 1: Treatment Protocol
Treatment is undertaken in single shot mode, with consecutive but not overlapping spots placed over the interior half of the trabecular meshwork. To determine the optimal level of energy for each patient, the energy level is gradually increased until the

Watch this video

SLT Clinical Footage 3: Heavily Pigmented Trabeculum
It is important to note that less energy is required when performing SLT on patients with a heavily pigmented trabeculum. In this case study, extensive mini-bubble formation was noted at the commencement of SLT treatment, indicating that the energy level

Watch this video

Retinal Rejuvenation Therapy: ABC News Australia 2010 “Seeing the Future”
Update on the Ellex 2RT research program featuring Prof. Erica Fletcher (Melbourne University) and Prof. Robyn Guymer (Centre for Eye Research, Australia).

Watch this video

Video Categories

Photocoagulation

  • Integre Pro Clinical Footage 1: Focal 532nm Green Laser Treatment in Central Retina
    Watch this video
  • Integre Pro Clinical Footage 2: Pan Retinal Photocoagulation (PRP)
    Watch this video
  • Integre Pro Clinical Footage 3: Pan Retinal Photocoagulation to Treat Diabetic Retinopathy
    Watch this video

SLT

YAG Photodisruption

Ellex 2RT

Featured Webinars

Photorejuvenation Therapy in the Treatment of Diabetic Maculopathy: Six Month Clinical Trial Results. AAO 2008.

John Marshall, PhD, FRCPath, FRCOphth (Hon)
Professor Marshall addresses initial clinical results for a London-based trial investigating the efficacy of Ellex 2RT for the treatment of diabetic macula edema.

View this webinar now
"Photoregeneration" - Tissue Interaction and Mechanisms of Action

Professor John Marshall, PhD
Professor Marshall will explain the mechanisms of action behind Selective Laser Trabeculoplasty and their relationship to emerging non-thermal therapies for restoring retinal function.

View this webinar now
The Importance of Ultrasound for the Vitreoretinal Surgeon

Yale L. Fisher, MD - Manhattan Eye, Ear & Throat Hospital, New York, USA
Learn about clinical pathologies of the posterior segment that can only be identified by ultrasound. Pre-operative ultrasound imaging thus becomes an essential component in ensuring a safe and successful surgery.

View this webinar now

Webinar Categories

Ellex 2RT

  • Photorejuvenation Therapy in the Treatment of Diabetic Maculopathy: Six Month Clinical Trial Results. AAO 2008.

    John Marshall, PhD, FRCPath, FRCOphth (Hon)
    Professor Marshall addresses initial clinical results for a London-based trial investigating the efficacy of Ellex 2RT for the treatment of diabetic macula edema.

    View this webinar now
  • "Photoregeneration" - Tissue Interaction and Mechanisms of Action

    Professor John Marshall, PhD
    Professor Marshall will explain the mechanisms of action behind Selective Laser Trabeculoplasty and their relationship to emerging non-thermal therapies for restoring retinal function.

    View this webinar now

Ultrasound

  • The Importance of Ultrasound for the Vitreoretinal Surgeon

    Yale L. Fisher, MD - Manhattan Eye, Ear & Throat Hospital, New York, USA
    Learn about clinical pathologies of the posterior segment that can only be identified by ultrasound. Pre-operative ultrasound imaging thus becomes an essential component in ensuring a safe and successful surgery.

    View this webinar now

Retinal Rejuvenation Therapy (Ellex 2RT)

  Retinal Rejuvenation Therapy: DME and AMD
John Marshall, PhD, FRCPath, FRCOphth (Hon). Euretina 2011.
  Nano-Laser Treatment Trial in Early AMD
Prof. Robyn Guymer, Melbourne, Australia. RANZCO 2010.
  The Effect of 2RT on the Mouse Eye
Prof. Erica Fletcher, Melbourne, Australia. RANZCO 2010.
  Trial of New Nanopulse Retinal Laser vs. Photocoagulation for the Treatment of Diabetic Macular Edema
Ass. Prof. Robert Casson, Royal Adelaide Hospital, Adelaide, Australia. RANZCO 2010.
  Selective Retinal Pigment Epithelial Treatment for Diabetic Macular Oedema: Six-Month Results
John Marshall, PhD, FRCPath, FRCOphth (Hon). Euretina 2009.
  Photorejuvenation Therapy in the Treatment of Diabetic Maculopasthy: Six-Month Clinical Trial Results.
John Marshall, PhD, FRCPath, FRCOphth (Hon). AAO 2008.

To view our complete listing of Ellex 2RT presentations, please visit ellex.com/2RT

 

Selective Laser Trabeculoplasty (SLT)

SLT KOL Presentations
Long-Term Results with SLT as Primary and Secondary Therapy
Lawrence F. Jindra, MD. ASCRS 2011.
A Decade of Experience with SLT
Madhu Nagar, MS Ophth, FRCS Ophth. ESCRS 2010.
Nine Years’ Experience with SLT
Lawrence F. Jindra, MD. ESCRS 2010.
Photoregeneration: Tissue Interaction and Mechanism of Action
John Marshall, PhD, FRCPath, FRCOphth (Hon). ESCRS 2007.
To view our complete listing of SLT KOL presentations, please visit slt-ellex.com

Technical and Clinical Notes

True Spot Optics
True Spot™ technology was developed by Ellex as a parfocal design with a minimal amount of defocus to take the edge off of corneal power density. It also provides an even, sharp-edged retinal burn, a high level of spot size accuracy and superior spot viewing. Download the True Spot™ Tech Note to learn more.

Superior Energy Distribution
Real-Time™ Energy Control has been developed by Ellex to ensure superior energy distribution. All major system parameters are monitored and actively adjusted via the laser cavity output in real-time to provide stable power delivery. As a result, each Ellex photocoagulator delivers predictable and consistent retinal burns with every pulse. Download the Real-Time™ Energy Control Tech Note to learn more.  

Ultra Q Technology
Ellex’s refined Ultra Q™ technology achieves consistent optical breakdown at an exact location using the lowest level of energy possible. This ensures high precision during surgery, lower incidence of intraocular lens (IOL) pitting, minimal energy exposure of the treated eye and fewer post-treatment complications. Download the Ultra Q™ Technology Tech Note to learn more. 
SLT: Primary Treatment for POAG
SLT: Repeatability
SLT: Normal Tension Glaucoma
SLT: Pigment Dispersion Glaucoma and Eyes with Highly-Pigmented Trabeculum

 

Whitepapers

The Yellow Wavelength: High-Power Minus Collateral Damage
Featuring insight from David Dyer, MD, Retina Associates, USA; Sharon Fekrat, MD, Associate Professor, Duke University Eye Center, USA; and Professor Michael Stur, University of Vienna, Austria
Retinal Photocoagulation: Wavelength Selection
A review of the yellow and red wavelengths
Selective Capsulotomy
Harvey L. Carter III MD. USA.
SLT: Efficacy, Compliance and Cost Effectiveness in the Treatment of Glaucoma
Ejaz Ansari, FRCOphth, MD. UK.

 

Treatment Guidelines

SLT Treatment Guidelines
The SLT treatment regimen is continually evolving and protocols vary from treatment of 360º, 180º or 90º of the trabecular meshwork. Quick and easy to perform, SLT is an outpatient procedure. During treatment, approximately 50 confluent spots are placed along the meshwork to treat a 180-degree angle. A large 400-micron spot size simplifies laser positioning on the meshwork.
English (Caucasian patients)
English (Asian patients)*
French
Spanish
*In Asia, there is generally a much higher incidence of angle-closure, open-angle glaucoma in patients with narrow angles, and normal tension glaucoma.
 

Always ensure that focus is maintained on the target tissue, and not on the laser beam spot. In addition, the treatment beam should cover the central part of the trabecular meshwork, where pigmentation is maximal.

Video courtesy of Prof. Philippe Denis, University Hospital of Lyon, France.